Conduit Pharmaceuticals Inc (NAS:CDT) Stock News, Headlines & Updates
Conduit Pharmaceuticals Inc Stock News from GuruFocus
- 1
Aug 12, 2024
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
Marketwired • 6:00am
Aug 08, 2024
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
Marketwired • 6:00am
Jul 16, 2024
Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
Marketwired • 7:00am
Jun 13, 2024
Conduit Pharmaceuticals to Join Russell 3000® Index
Marketwired • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news